Vapotherm is a global medical technology company primarily focused on the development and commercialization of its proprietary High Velocity Therapy products that are used to treat patients of various ages suffering from respiratory distress. Co.'s High Velocity Therapy products deliver non-invasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a small-bore nasal interface. Co. provides four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Co.'s Precision Flow systems include a capital unit, a single-use disposable and a nasal interface. The VAPO stock yearly return is shown above.
The yearly return on the VAPO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the VAPO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|